PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. The collaboration brings together ALS Therapy Development Institute (ALS TDI), LifeArc, and Axol Bioscience to develop high-quality induced pluripotent […]
Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform Cambridge, UK: Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP). The fundraise was led by Parkwalk, and […]
Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs Cambridge, UK – Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of […]
Pioneering genomics researcher and Methods Development Lab director joins n6 to accelerate adoption of AutoNorm across the research and clinical genomics community PLEASANTON, Calif. — n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al’Khafaji […]
LumaCyte Analytical Method Included in Newly Published ISO Global Standard for Viral Vector Quantification LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921‑2:2026: Biotechnology — Gene delivery systems — Part 2: Quantification methods for viral vectors. Published earlier this […]
Group photo of representatives for the agreement signature. From left to right: Prof. KWONG Lai Wan, Dora, Clinical Professor, Department of Clinical Oncology, HKU; Dr. Paul WANG, Director of Techno-Entrepreneurship Core, HKU; Dr. ZHANG Yong, CEO of BiomOrgan Limited; Prof. YUEN Kwok-Yung, Chair Professor, Department of Microbiology, HKU & Managing Director, CVVT; Prof. ZHOU Jie, […]
COLUMBIA, Md. — Shimadzu Scientific Instruments Inc., a Shimadzu Group company, has officially opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications and lab automation solutions tailored to the needs of pharmaceutical […]
SAN JOSE, Calif. & RENO, Nev. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide. The companies are collaborating to develop verified automation methods and workflows for Takara Bio […]
Enables expression of active GPCRs in 48 hours Panel supports screening to scale-up on eProtein Discovery Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs). Building on the eProtein Discovery™ membrane […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today the appointment of Camila Japur as Chief Financial Officer, who will join the company on June 1, 2026. Camila currently serves as Group CFO of u-blox, where she has successfully led transformation initiatives, driving cost efficiency, strengthening financial processes, and enhancing capital market […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
